24 matches for your search in the start-up spotlight
rss
University of Oxford spinout accelerates commercial expansion in the US of its innovative stroke AI imaging solution, with its demonstrated impact on vital treatments
25-Mar-2025
Brainomix, a company pioneering AI-powered imaging tools in stroke and lung fibrosis, announced the completion of a £14M ($18M) Series C investment round. The round is co-led by prominent healthtech investors that include existing investors, Parkwalk Advisors, the UK’s largest growth EIS fund ...
Colossal Secures $200M in Series C Funding From TWG Global
21-Jan-2025
Colossal Biosciences, the world’s first de-extinction company, has announced $200M in a Series C financing by TWG Global, a diversified holding company with operating businesses and investments in technology/AI, financial services, private lending and sports and media, jointly led by Mark Walter ...
“ImmunOs Therapeutics has a very innovative approach to target myeloid checkpoints which are potentially the next major breakthrough in immuno-oncology”
24-Sep-2024
ImmunOs Therapeutics AG, a biopharmaceutical company leveraging its unique immune system modulating HLA-based technology platform to develop first-in-class therapeutics for the treatment of cancer and autoimmune diseases, announced the closing of a Series C financing round of $11 million. The ...
22-Aug-2024
Caresyntax, a vendor-neutral precision surgery platform, announced raising a total commitment of $180 million through a series C extension and growth debt expansion round. Investors in the $180 million round include Symbiotic Capital, MTIP AG, BIONIQ Capital, PFM Health Sciences, Pictet ...
SphingoTec GmbH has successfully secured funding to drive its global expansion, including the US market, through strategic collaborations.
13-Aug-2024
SphingoTec GmbH announces the successful closing of a Series C financing round. The raised capital will allow the company to reach profitability through sustained and strategic commercialization of its products. This includes supporting market development, out-licensing activities, and close ...
Elias Papatheodorou moves from Chair of the Board to CEO of HepaRegeniX
15-Jul-2024
HepaRegeniX GmbH, a clinical stage company developing novel regenerative therapies for the treatment of acute and chronic liver diseases, announced the closing of a Series C round led by Vesalius Biocapital IV with participation of existing investors Novo Holdings, Boehringer Ingelheim Venture ...
Proceeds will be used to expand Phase II of best-in-class anti-BK Virus antibody to become the largest study ever conducted for BK virus infection in kidney transplantation
21-May-2024
Memo Therapeutics AG (or “MTx”) announces that it has successfully raised CHF 20 million as part of an extension of its Series C financing, bringing the total amount raised in the funding round to CHF 45 million. The new funding will be used to bolster the clinical advancement of MTx’s lead ...
Smart Reporting successfully closes financing round for 23 million euros
24-Apr-2024
Smart Reporting has successfully completed a financing round of 23 million euros. TVM Capital Life Science (lead investor) and Bayern Kapital are newly on board in the Series C funding, while the existing investors are also participating in the financing round. The capital raised will primarily ...
26-Jan-2024
Onera Health announced the completion of its Series C financing round. This latest funding round brings Onera’s total investment to date to more than €55 million. The round was led by new investor EQT Life Sciences, investing from its EQT Health Economics 3 fund, co-led by new investor Gimv, and ...
Product portfolio expanded to include larger mobile battery storage systems
24-Jan-2024
Instagrid announces a Series C funding round of $95 million. The round was led by Teachers’ Venture Growth (TVG), part of the C$250bn Ontario Teachers’ Pension Plan, with participation from Morgan Stanley Investment Management (MSIM) 1GT climate private equity strategy. Existing investors Energy ...
